Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Sergio Giralt

1-50 of 540 results

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

scientific article (publication date: 19 February 2014)

Defining the intensity of conditioning regimens: working definitions

scientific article

Lenalidomide after stem-cell transplantation for multiple myeloma

scientific article

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

scientific article published on 01 February 1997

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

scientific article published on 01 August 1998

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

scientific article

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

scientific article

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

scientific article

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

scientific article published on 8 April 2004

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

scientific article published in July 2002

Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission or with Myelodysplastic Syndrome

scholarly article published in 2010

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study

scientific article

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

scientific article published on 11 May 2015

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

scientific article published on 03 February 2011

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

scientific article published on 15 April 2004

Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome

scientific article

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

scientific article published on 01 June 1997

Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group

scientific article published on 18 October 2010

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

scientific article

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

scientific article

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

scientific article published on December 15, 2001

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

scientific article published on September 29, 2011

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

scientific article

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

scientific article

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

scientific article published in December 1998

Importance of achieving a complete response in multiple myeloma, and the impact of novel agents

scientific article published on 12 April 2010

Adenovirus infections in adult recipients of blood and marrow transplants

scientific article published on 9 March 2001

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

scientific article published on 26 June 2009

Outcome of transplantation for myelofibrosis

scientific article

Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

scientific article published on 12 October 2006

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations

scientific article published on 17 October 2013

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation

scientific article

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

scientific article

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

scientific article

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

scientific article published on 13 February 2017

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

scientific article

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

scientific article

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

scientific article

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

scientific article

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

scientific article

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma

scientific article

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

scientific article published on 01 January 2002

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

scientific article

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

scientific article published on 01 May 1997

International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma

scientific article published on 09 August 2010

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

scientific article

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

scientific article

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

scientific article

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

scientific article published on 03 July 2003

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

scientific article published on 6 August 2015